• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻腔内给予氯胺酮对大鼠面部疼痛模型的镇痛作用。

Analgesic Effects of Intranasal Ketamine in Rat Models of Facial Pain.

出版信息

J Oral Facial Pain Headache. 2018 Summer;32(3):238–346. doi: 10.11607/ofph.1973. Epub 2018 Apr 25.

DOI:10.11607/ofph.1973
PMID:29697717
Abstract

AIMS

To assess the analgesic effect of intranasal administration of S-ketamine in different rat models of facial pain.

METHODS

Nociceptive responses induced by formalin injected into the upper lip and facial hyperalgesia induced by capsaicin or carrageenan injected into the upper lip were used to evaluate the analgesic effect of intranasal ketamine in acute facial pain models in rats (n = 173). The effect of intranasal ketamine on heat and mechanical hyperalgesia induced by constriction of the infraorbital nerve (CION) was also evaluated. In addition, locomotor activity in the open field test was assessed after intranasal ketamine administration. Two-way repeated measures analysis of variance followed by Bonferroni post hoc correction were used to analyze all data.

RESULTS

Intranasal ketamine (0.5 mg/kg) failed to modify the first phase of the orofacial formalin test, but reduced the second phase by about 40%. Intranasal ketamine also reduced the facial heat hyperalgesia induced by capsaicin and carrageenan. In the CION model, intranasal ketamine at 0.5 mg/kg reversed the heat hyperalgesia and at 1 mg/kg attenuated the mechanical hyperalgesia 4 and 14 days after the surgery, respectively. The open field test did not reveal locomotor deficits in rats treated with intranasal ketamine.

CONCLUSION

This study has demonstrated that intranasal ketamine produces analgesic effects in inflammatory and neuropathic facial pain models and may represent an adjuvant in the treatment of such conditions, especially when rapid pain relief is needed.

摘要

目的

评估 S-氯胺酮经鼻给药在不同大鼠面部疼痛模型中的镇痛效果。

方法

采用福尔马林注射于上唇诱导的伤害性反应和辣椒素或角叉菜胶注射于上唇诱导的面部痛觉过敏来评估 S-氯胺酮经鼻给药对大鼠急性面部疼痛模型的镇痛作用(n = 173)。还评估了 S-氯胺酮经鼻给药对眶下神经缩窄(CION)引起的热和机械性痛觉过敏的影响。此外,还评估了 S-氯胺酮经鼻给药后的旷场试验中的运动活性。采用双向重复测量方差分析,随后进行 Bonferroni 事后校正来分析所有数据。

结果

经鼻给予 S-氯胺酮(0.5mg/kg)不能改变口腔福尔马林测试的第一阶段,但可将第二阶段减少约 40%。经鼻给予 S-氯胺酮还可减轻由辣椒素和角叉菜胶引起的面部热痛觉过敏。在 CION 模型中,经鼻给予 0.5mg/kg 的 S-氯胺酮可逆转热痛觉过敏,而 1mg/kg 的 S-氯胺酮分别在手术后 4 天和 14 天减轻机械性痛觉过敏。旷场试验未显示经鼻给予 S-氯胺酮的大鼠存在运动缺陷。

结论

本研究表明,S-氯胺酮经鼻给药在炎症性和神经性面部疼痛模型中具有镇痛作用,可能是治疗这些疾病的辅助手段,特别是在需要快速缓解疼痛时。

相似文献

1
Analgesic Effects of Intranasal Ketamine in Rat Models of Facial Pain.鼻腔内给予氯胺酮对大鼠面部疼痛模型的镇痛作用。
J Oral Facial Pain Headache. 2018 Summer;32(3):238–346. doi: 10.11607/ofph.1973. Epub 2018 Apr 25.
2
Pregabalin reduces acute inflammatory and persistent pain associated with nerve injury and cancer in rat models of orofacial pain.普瑞巴林可减轻与口腔颌面部疼痛相关的大鼠模型中神经损伤和癌症引起的急性炎症和持续性疼痛。
J Oral Facial Pain Headache. 2014 Fall;28(4):350-9. doi: 10.11607/ofph.1317.
3
Intraganglionar resiniferatoxin prevents orofacial inflammatory and neuropathic hyperalgesia.神经节内树脂毒素可预防口面部炎症性和神经性痛觉过敏。
Behav Pharmacol. 2014 Apr;25(2):112-8. doi: 10.1097/FBP.0000000000000024.
4
Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models.外周物质 P 和神经激肽-1 受体在炎症性和神经性口腔面部疼痛模型中起作用。
Neuropeptides. 2013 Jun;47(3):199-206. doi: 10.1016/j.npep.2012.10.005. Epub 2012 Nov 22.
5
Sex Dimorphism in Resolvin D5-induced Analgesia in Rat Models of Trigeminal Pain.性别二态性在三叉神经痛大鼠模型中解析素 D5 诱导的镇痛作用中的作用。
J Pain. 2023 May;24(5):717-729. doi: 10.1016/j.jpain.2022.12.013. Epub 2022 Dec 28.
6
The opposing contribution of neurotrophin-3 and nerve growth factor to orofacial heat hyperalgesia in rats.神经营养因子-3和神经生长因子对大鼠口腔面部热痛觉过敏的相反作用。
Behav Pharmacol. 2020 Feb;31(1):27-33. doi: 10.1097/FBP.0000000000000503.
7
Etanercept reduces thermal and mechanical orofacial hyperalgesia following inflammation and neuropathic injury.依那西普可减轻炎症和神经性损伤后出现的热和机械性口腔面部痛觉过敏。
Eur J Pain. 2014 Aug;18(7):957-67. doi: 10.1002/j.1532-2149.2013.00441.x. Epub 2014 Jan 7.
8
Contribution and interaction of kinin receptors and dynorphin A in a model of trigeminal neuropathic pain in mice.激肽受体与强啡肽A在小鼠三叉神经病理性疼痛模型中的作用及相互作用
Neuroscience. 2015 Aug 6;300:189-200. doi: 10.1016/j.neuroscience.2015.05.015. Epub 2015 May 14.
9
Antinociception Induced by Copper Salt Revisited: Interaction with Ketamine in Formalin-Induced Intraplantar and Orofacial Pain in Mice.重新探讨铜盐的镇痛作用:在福尔马林诱导的足底和口腔面部疼痛模型中,与氯胺酮的相互作用。
J Oral Facial Pain Headache. 2018 Summer;32(3):247–257. doi: 10.11607/ofph.1961. Epub 2018 May 15.
10
Long-Term Antihyperalgesic and Opioid-Sparing Effects of 5-Day Ketamine and Morphine Infusion ("Burst Ketamine") in Diabetic Neuropathic Rats.5天氯胺酮和吗啡输注(“冲击性氯胺酮”)对糖尿病性神经病变大鼠的长期抗痛觉过敏及阿片类药物节省效应
Pain Med. 2015 Sep;16(9):1781-93. doi: 10.1111/pme.12735. Epub 2015 Mar 20.

引用本文的文献

1
Intranasal Administration of the Combination of Dextro-Ketamine and Dexmedetomidine for Treatment of Diabetic Neuropathic Pain in Rats.右美沙酮与右美托咪定联合鼻内给药治疗大鼠糖尿病性神经病理性疼痛
J Pain Res. 2025 Jan 9;18:127-136. doi: 10.2147/JPR.S480894. eCollection 2025.
2
Exploring the Therapeutic Potential of N-Methyl-D-Aspartate Receptor Antagonists in Neuropathic Pain Management.探讨 N-甲基-D-天冬氨酸受体拮抗剂在神经性疼痛管理中的治疗潜力。
Int J Mol Sci. 2024 Oct 16;25(20):11111. doi: 10.3390/ijms252011111.
3
Ketamine - An Imperfect Wonder Drug?
氯胺酮——一种不完美的神奇药物?
Biochem Pharmacol. 2024 Nov;229:116516. doi: 10.1016/j.bcp.2024.116516. Epub 2024 Aug 30.
4
Intranasal Ketamine for Acute Pain: Behavioral and Neurophysiological Safety Analysis in Mice.鼻内注射氯胺酮治疗急性疼痛:小鼠行为学和神经生理学安全性分析
Curr Ther Res Clin Exp. 2021 Mar 11;94:100627. doi: 10.1016/j.curtheres.2021.100627. eCollection 2021.
5
Efficacy of ketamine in relieving neuropathic pain: a systematic review and meta-analysis of animal studies.氯胺酮缓解神经性疼痛的疗效:动物研究的系统评价和荟萃分析。
Pain. 2021 Sep 1;162(9):2320-2330. doi: 10.1097/j.pain.0000000000002231.
6
Ketamine Use for Cancer and Chronic Pain Management.氯胺酮在癌症与慢性疼痛管理中的应用。
Front Pharmacol. 2021 Feb 2;11:599721. doi: 10.3389/fphar.2020.599721. eCollection 2020.
7
KEA-1010, a ketamine ester analogue, retains analgesic and sedative potency but is devoid of Psychomimetic effects.KEA-1010 是一种氯胺酮酯类似物,保留了镇痛和镇静作用,但没有致幻作用。
BMC Pharmacol Toxicol. 2019 Dec 19;20(1):85. doi: 10.1186/s40360-019-0374-y.